查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
癌症支持治療藥物市場規模 - 按藥物類別、癌症類型、配銷通路、全球預測（2023 - 2032）
市場調查報告書
商品編碼
1359588

癌症支持治療藥物市場規模 - 按藥物類別、癌症類型、配銷通路、全球預測（2023 - 2032）

Cancer Supportive Care Drugs Market Size - By Drug Class, Cancer type, Distribution Channel, Global Forecast (2023 - 2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 121 Pages | 商品交期: 2-3個工作天內

價格

由於全球癌症發生率不斷上升，預計 2023 年至 2032 年癌症支持治療藥物市場規模的複合年成長率為 1.9%。根據美國癌症統計局的資料，2020年新增癌症病例超過150萬例，其中死亡人數近602,347人。隨著癌症病例數量持續增加，對減輕癌症治療副作用的療法（例如化療和放射療法）的需求正在激增。

此外，人們越來越意識到癌症治療期間生活品質的重要性，也推動了這些藥物的使用。隨著患者尋求控制症狀並保持更高水平的舒適度和幸福感的方法，癌症支持護理解決方案將獲得關注。

癌症支持治療藥物市場根據藥物類別、癌症類型、配銷通路和地區分類。

預計2023 年至2032 年，鴉片類藥物領域的複合年成長率將達到2.4% 左右。鴉片類藥物因其在控制癌症相關疼痛方面的有效性而聞名，因此越來越多的患者開始接受鴉片類藥物的治療。隨著鴉片類藥物配方的進步，重點已轉向實現最佳疼痛緩解，同時最大限度地減少副作用。這不僅提高了患者的舒適度，而且還提供了一種更全面的方法來管理癌症症狀。

肺癌領域預計在 2023 年和 2032 年期間複合年成長率為 2.5%，因為它是最受歡迎和最具侵襲性的癌症類型之一。肺癌患者常常會出現一系列令人痛苦的症狀，包括疼痛、呼吸困難和疲勞。因此，對針對肺癌患者特定需求的支持性護理藥物的需求很高。用於改善患者生活品質的肺癌創新藥物和療法的開發正在推動該行業的成長。

受惠於強大的醫療基礎設施、廣泛的研發活動和高癌症盛行率，北美癌症支持治療藥物產業預計 2023 年至 2032 年複合年成長率為 1.7%。美國和加拿大處於推動癌症支持治療的最前沿，大力投資研發，並確保患者能夠獲得最新、最有效的支持性治療藥物。北美對癌症治療期間患者舒適度和福祉的重視將繼續推動市場擴張。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：癌症支持治療藥物市場產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 癌症發生率和盛行率上升
      • 癌症治療技術不斷進步
      • 老年人口不斷增加
      • 數位健康日益一體化
      • 提高患者和醫療保健專業人員對支持性護理藥物的可用性和益處的認知
    • 產業陷阱與挑戰
      • 替代療法或補充療法的可用性
      • 醫療資源有限
      • 不良反應藥物
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司定位矩陣
  • 主要市場參與者的競爭分析
  • 戰略儀表板

第 5 章：癌症支持治療藥物市場規模和預測：按藥物類別

  • 主要動向：依藥物類別
  • G-CSF（粒細胞集落刺激因子）
  • ESA（紅血球生成刺激劑）
  • 止吐藥
  • 雙磷酸鹽
  • 鴉片類藥物
  • 非類固醇抗發炎藥
  • 其他藥品

第 6 章：癌症支持治療藥物市場規模與預測：按癌症類型

  • 主要動力向：按癌症類型
  • 乳癌
  • 肺癌
  • 黑色素瘤
  • 攝護腺癌
  • 大腸直腸癌
  • 肝癌
  • 胃癌
  • 其他癌症類型

第 7 章：癌症支持治療藥物市場規模及預測：按分銷管道

  • 主要動向：按配銷通路
  • 醫院藥房
  • 藥局和零售藥局
  • 網路藥局

第 8 章：癌症支持治療藥物市場規模與預測：按地區

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Amgen, Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Heron Therapeutics, Inc.
  • Novartis AG
  • GSK plc
  • F. Hoffmann-La Roche Ltd.
  • Helsinn Healthcare SA
  • Teva Pharmaceuticals Industries Ltd.
  • Fagron Group
Product Code: 6489

Cancer supportive care drugs market size is predicted to witness 1.9% CAGR from 2023 to 2032 due to the escalating incidence of cancer worldwide. According to the data from the United States Cancer Statistics, more than 1.5 million new cancer cases were reported in 2020, out of which nearly 602,347 deaths were reported. As the number of cancer cases continues to rise, the demand for therapies that alleviate the side effects of cancer treatment, such as chemotherapy and radiation therapy, is surging.

Additionally, the growing awareness about the importance of quality of life during cancer treatment has fueled the usage of these drugs. As patients seek ways to manage their symptoms and maintain a higher level of comfort and well-being, the cancer support care solutions will gain traction.

Cancer supportive care drugs market is divided based on drug class, cancer type, distribution channel, and region.

The opioids segment is expected to record around 2.4% CAGR from 2023 to 2032. As opioids are known for their effectiveness in managing cancer-related pain, they are increasingly prescribed to patients undergoing cancer treatment. With advancements in opioid formulations, the focus has shifted toward achieving optimal pain relief while minimizing side effects. This is not only enhancing patient comfort but also providing a more comprehensive approach to managing cancer symptoms.

The lung cancer segment is anticipated to observe 2.5% CAGR during 2023 and 2032 as it is one of the most prevalent and aggressive types of cancer. Patients with lung cancer often suffer from a range of distressing symptoms, including pain, breathlessness, and fatigue. As a result, there is a high demand for supportive care drugs tailored to the specific needs of lung cancer patients. The development of innovative drugs and therapies for lung cancer for improving the quality of life for patients is driving the industry growth.

North America cancer supportive care drugs industry is expected to witness 1.7% CAGR from 2023 to 2032, favored by a robust healthcare infrastructure, extensive R&D activities, and high cancer prevalence. The United States and Canada are at the forefront of advancing cancer supportive care, investing heavily in R&D, and ensuring that patients have access to the latest and most effective supportive care drugs. The emphasis on patient comfort and well-being during cancer treatment in North America will continue to drive the market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global cancer supportive care drugs market 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Drug class trends
    • 2.1.4 Cancer type trends
    • 2.1.5 Distribution channel trends

Chapter 3 Cancer Supportive Care Drugs Market Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence and prevalence of cancer
      • 3.2.1.2 Increasing technological advancements in cancer therapies
      • 3.2.1.3 Rising geriatric population
      • 3.2.1.4 Growing integration of digital health
      • 3.2.1.5 Increasing awareness among patients and healthcare professionals about the availability and benefits of supportive care drugs
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of alternative therapies or complementary treatments
      • 3.2.2.2 Limited healthcare resources
      • 3.2.2.3 Adverse effect drugs
  • 3.3 Growth potential analysis
    • 3.3.1 By drug class
    • 3.3.2 By cancer type
    • 3.3.3 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company positioning matrix, 2022
  • 4.4 Competitive analysis of major market players, 2022
  • 4.5 Strategy dashboard, 2022

Chapter 5 Cancer Supportive Care Drugs Market Size and Forecast, By Drug class (USD Million)

  • 5.1 Key trends, by drug class
  • 5.2 G-CSFs (Granulocyte-colony Stimulating Factors)
  • 5.3 ESAs (Erythropoiesis Stimulating Agents)
  • 5.4 Anti-emetics
  • 5.5 Bisphosphonates
  • 5.6 Opioids
  • 5.7 NSAIDs
  • 5.8 Other drugs

Chapter 6 Cancer Supportive Care Drugs Market Size and Forecast, By Cancer type (USD Million)

  • 6.1 Key trends, by cancer type
  • 6.2 Breast cancer
  • 6.3 Lung cancer
  • 6.4 Melanoma
  • 6.5 Prostate cancer
  • 6.6 Colorectal cancer
  • 6.7 Liver cancer
  • 6.8 Stomach cancer
  • 6.9 Other cancer types

Chapter 7 Cancer Supportive Care Drugs Market Size and Forecast, By Distribution channel (USD Million)

  • 7.1 Key trends, by distribution channel
  • 7.2 Hospital pharmacies
  • 7.3 Drug stores and retail pharmacies
  • 7.4 Online pharmacies

Chapter 8 Cancer Supportive Care Drugs Market Size and Forecast, By Region (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Amgen, Inc.
  • 9.2 Merck & Co., Inc.
  • 9.3 Johnson & Johnson Services, Inc.
  • 9.4 Heron Therapeutics, Inc.
  • 9.5 Novartis AG
  • 9.6 GSK plc
  • 9.7 F. Hoffmann-La Roche Ltd.
  • 9.8 Helsinn Healthcare SA
  • 9.9 Teva Pharmaceuticals Industries Ltd.
  • 9.10 Fagron Group

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by drug class (2022)
  • TABLE 3 Market share, by cancer type (2022)
  • TABLE 4 Market share, by distribution channel (2022)
  • TABLE 5 Global cancer supportive care drugs market size, by region, 2018-2022 (USD Million)
  • TABLE 6 Global cancer supportive care drugs market size, by region, 2023-2032 (USD Million)
  • TABLE 7 Global cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 8 Global cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 9 Global cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 10 Global cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 11 Global cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 12 Global cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 13 Industry impact forces
  • TABLE 14 G-CSFs (Granulocyte-colony Stimulating Factors) market size, 2018-2022 (USD Million)
  • TABLE 15 G-CSFs (Granulocyte-colony Stimulating Factors) market size, 2023-2032 (USD Million)
  • TABLE 16 ESAs (Erythropoiesis Stimulating Agents) market size, 2018-2022 (USD Million)
  • TABLE 17 ESAs (Erythropoiesis Stimulating Agents) market size, 2023-2032 (USD Million)
  • TABLE 18 Anti-emetics market size, 2018-2022 (USD Million)
  • TABLE 19 Anti-emetics market size, 2023-2032 (USD Million)
  • TABLE 20 Bisphosphonates market size, 2018-2022 (USD Million)
  • TABLE 21 Bisphosphonates market size, 2023-2032 (USD Million)
  • TABLE 22 Opioids market size, 2018-2022 (USD Million)
  • TABLE 23 Opioids market size, 2023-2032 (USD Million)
  • TABLE 24 NSAIDs market size, 2018-2022 (USD Million)
  • TABLE 25 NSAIDs market size, 2023-2032 (USD Million)
  • TABLE 26 Other drugs market size, 2018-2022 (USD Million)
  • TABLE 27 Other drugs market size, 2023-2032 (USD Million)
  • TABLE 28 Breast cancer market size, 2018-2022 (USD Million)
  • TABLE 29 Breast cancer market size, 2023-2032 (USD Million)
  • TABLE 30 Lung cancer market size, 2018-2022 (USD Million)
  • TABLE 31 Lung cancer market size, 2023-2032 (USD Million)
  • TABLE 32 Melanoma market size, 2018-2022 (USD Million)
  • TABLE 33 Melanoma market size, 2023-2032 (USD Million)
  • TABLE 34 Prostate cancer market size, 2018-2022 (USD Million)
  • TABLE 35 Prostate cancer market size, 2023-2032 (USD Million)
  • TABLE 36 Stomach cancer market size, 2018-2022 (USD Million)
  • TABLE 37 Stomach cancer market size, 2023-2032 (USD Million)
  • TABLE 38 Liver cancer market size, 2018-2022 (USD Million)
  • TABLE 39 Liver cancer market size, 2023-2032 (USD Million)
  • TABLE 40 Colorectal cancer market size, 2018-2022 (USD Million)
  • TABLE 41 Colorectal cancer market size, 2023-2032 (USD Million)
  • TABLE 42 Other cancer types market size, 2018-2022 (USD Million)
  • TABLE 43 Other cancer types market size, 2023-2032 (USD Million)
  • TABLE 44 Hospital pharmacies market size, 2018-2022 (USD Million)
  • TABLE 45 Hospital pharmacies market size, 2023-2032 (USD Million)
  • TABLE 46 Drug stores and retail pharmacies market size, 2018-2022 (USD Million)
  • TABLE 47 Drug stores and retail pharmacies market size, 2023-2032 (USD Million)
  • TABLE 48 Online pharmacies market size, 2018-2022 (USD Million)
  • TABLE 49 Online pharmacies market size, 2023-2032 (USD Million)
  • TABLE 50 North America cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
  • TABLE 51 North America cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
  • TABLE 52 North America cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 53 North America cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 54 North America cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 55 North America cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 56 North America cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 57 North America cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 58 U.S. cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 59 U.S. cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 60 U.S. cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 61 U.S. cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 62 U.S. cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 63 U.S. cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 64 Canada cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 65 Canada cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 66 Canada cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 67 Canada cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 68 Canada cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 69 Canada cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 70 Europe cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
  • TABLE 71 Europe cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
  • TABLE 72 Europe cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 73 Europe cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 74 Europe cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 75 Europe cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 76 Europe cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 77 Europe cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 78 Germany cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 79 Germany cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 80 Germany cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 81 Germany cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 82 Germany cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 83 Germany cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 84 U.K. cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 85 U.K. cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 86 U.K. cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 87 U.K. cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 88 U.K. cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 89 U.K. cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 90 France cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 91 France cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 92 France cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 93 France cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 94 France cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 95 France cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 96 Spain cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 97 Spain cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 98 Spain cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 99 Spain cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 100 Spain cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 101 Spain cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 102 Italy cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 103 Italy cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 104 Italy cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 105 Italy cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 106 Italy cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 107 Italy cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 108 Rest of Europe cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 109 Rest of Europe cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 110 Rest of Europe cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 111 Rest of Europe cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 112 Rest of Europe cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 113 Rest of Europe cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 114 Asia Pacific cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
  • TABLE 115 Asia Pacific cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
  • TABLE 116 Asia Pacific cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 117 Asia Pacific cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 118 Asia Pacific cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 119 Asia Pacific cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 120 Asia Pacific cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 121 Asia Pacific cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 122 Japan cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 123 Japan cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 124 Japan cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 125 Japan cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 126 Japan cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 127 Japan cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 128 China cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 129 China cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 130 China cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 131 China cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 132 China cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 133 China cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 134 India cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 135 India cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 136 India cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 137 India cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 138 India cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 139 India cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 140 Australia cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 141 Australia cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 142 Australia cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 143 Australia cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 144 Australia cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 145 Australia cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 146 Rest of Asia Pacific cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 147 Rest of Asia Pacific cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 148 Rest of Asia Pacific cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 149 Rest of Asia Pacific cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 150 Rest of Asia Pacific cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 151 Rest of Asia Pacific cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 152 Latin America cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
  • TABLE 153 Latin America cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
  • TABLE 154 Latin America cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 155 Latin America cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 156 Latin America cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 157 Latin America cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 158 Latin America cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 159 Latin America cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 160 Brazil cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 161 Brazil cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 162 Brazil cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 163 Brazil cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 164 Brazil cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 165 Brazil cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 166 Mexico cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 167 Mexico cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 168 Mexico cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 169 Mexico cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 170 Mexico cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 171 Mexico cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 172 Rest of Latin America cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 173 Rest of Latin America cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 174 Rest of Latin America cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 175 Rest of Latin America cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 176 Rest of Latin America cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 177 Rest of Latin America cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 178 Middle East & Africa cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
  • TABLE 179 Middle East & Africa cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
  • TABLE 180 Middle East & Africa cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 181 Middle East & Africa cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 182 Middle East & Africa cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 183 Middle East & Africa cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 184 Middle East & Africa cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 185 Middle East & Africa cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 186 South Africa cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 187 South Africa cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 188 South Africa cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 189 South Africa cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 190 South Africa cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 191 South Africa cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 192 Saudi Arabia cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 193 Saudi Arabia cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 194 Saudi Arabia cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 195 Saudi Arabia cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 196 Saudi Arabia cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 197 Saudi Arabia cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 198 Rest of Middle East & Africa cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
  • TABLE 199 Rest of Middle East & Africa cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
  • TABLE 200 Rest of Middle East & Africa cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 201 Rest of Middle East & Africa cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 202 Rest of Middle East & Africa cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 203 Rest of Middle East & Africa cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Cancer supportive care drugs industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug class
  • FIG 8 Growth potential analysis, by cancer type
  • FIG 9 Growth potential analysis, by distribution
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 2022
  • FIG 13 Competitive analysis of major market players, 2022
  • FIG 14 Competitive positioning matrix, 2022
  • FIG 15 Strategic dashboard, 2022